Global Health Sciences Fund (Quark Venture LP and GF Securities) Contributes to Volastra Therapeutics’ $12 Million Seed Financing for Company’s Development of Novel Metastatic Cancer Therapies
11 févr. 2020 08h33 HE
|
Quark Venture
VANCOUVER, British Columbia, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Quark Venture LP and GF Securities today announced that they have contributed to the $12 million seed financing to launch Volastra...